Healy et al. (2006) used transcriptional profiling analysis to identify S100A8/A9 as a novel predictor of MI by examining platelet mRNA transcripts and showed that S100A9 mRNA levels in patients with STEMI were strikingly elevated compared to those of patients with stable coronary artery disease. This evidence concerns the gene S100A8 and coronary artery disorder.